PATENT CLAIM ANALYSIS

Application Number: 16085234
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "130100"]

Abstract:
The present invention provides for a new therapeutic tools capable of treating infectious diseases, in particular, a new pharmaceutical composition comprising an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe Community Acquired Pneumonia (sCAP).

Claim (Index 9):
The immunoglobulin preparation for use according to  claim 1 , wherein the immunoglobulin preparation has not been treated with beta-propiolactone.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13817414', '14529400', '13655686', '15348121', '14778114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6824633444674417
- 35 USC 102 Novelty (BERT): 0.5159395380858587
- Combined Prediction Score: 0.6658109638292835
- Mean Citation Score: 230.49716
- Max Citation Score: 256.71954
- Similarity Product: 170.85566384112954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test